1. Home
  2. ALLT vs SIGA Comparison

ALLT vs SIGA Comparison

Compare ALLT & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$6.40

Market Cap

519.6M

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$5.25

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
SIGA
Founded
1996
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
519.6M
401.0M
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
ALLT
SIGA
Price
$6.40
$5.25
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$12.25
N/A
AVG Volume (30 Days)
691.6K
475.0K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
10.97%
EPS Growth
N/A
N/A
EPS
N/A
0.32
Revenue
N/A
N/A
Revenue This Year
$14.86
N/A
Revenue Next Year
$12.10
$132.36
P/E Ratio
$469.21
$17.09
Revenue Growth
N/A
N/A
52 Week Low
$4.37
$4.95
52 Week High
$11.92
$9.62

Technical Indicators

Market Signals
Indicator
ALLT
SIGA
Relative Strength Index (RSI) 27.56 25.09
Support Level $6.20 $5.21
Resistance Level $8.20 $6.98
Average True Range (ATR) 0.55 0.26
MACD -0.06 -0.13
Stochastic Oscillator 6.30 5.31

Price Performance

Historical Comparison
ALLT
SIGA

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: